Vimarsana
Biggest News Aggregation in the World

Page 2 - Cross Labcell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cross Labcell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cross Labcell Today - Breaking & Trending Today

Global Drug Delivery Partnering Deals Terms and Agreements 2015-2022: Access to Headline, Upfront, Milestone and Royalty Data - Vimarsana News

Global Drug Delivery Partnering Deals Terms and Agreements 2015-2022: Access to Headline, Upfront, Milestone and Royalty Data

/PRNewswire/ -- The "Global Drug Delivery Partnering Terms and Agreements 2015-2022" report has been added to ResearchAndMarkets.com's offering. The Global...

GC Cell Inks First Licensing Agreement for Immuncell-LC® With Rivaara Immune Private Limited in India - Vimarsana News

GC Cell Inks First Licensing Agreement for Immuncell-LC® With Rivaara Immune Private Limited in India

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
GC Pharma Reports Q1 2021 Results - Vimarsana News

GC Pharma Reports Q1 2021 Results

Press release content from Business Wire. The AP news staff was not involved in its creation. GC Pharma Reports Q1 2021 Results April 29, 2021 GMT YONGIN, South Korea--(BUSINESS WIRE)--Apr 28, 2021-- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the three months ended 31 March 2021. First-Quarter Reported Results(1)   (2) Financial Highlights Delivered total revenue decline of 8.3% KRW 282.2 billion (2019 Q1: 307.8 billion), and operating profit decreased 18.0% to KRW...

Source: apnews.com
GC Pharma Reports Full Year 2020 Results - Vimarsana News

GC Pharma Reports Full Year 2020 Results

Press release content from Business Wire. The AP news staff was not involved in its creation. GC Pharma Reports Full Year 2020 Results February 9, 2021 GMT YONGIN, South Korea--(BUSINESS WIRE)--Feb 9, 2021-- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited financial results for the year ended 31 December 2019. Key Figures (1) - (1) Results from continuing operations (Green Cross MS’ blood bag business has been classified as discontinued operations) (2) Results and percentages compare full financial year ...

Source: apnews.com